Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 13/20 | 0.63 |
| ▸ | RARG | P13631 | 13/20 | 0.63 |
| ▸ | RARA | P10276 | 12/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL383420 | 0.99 | RARB (0.62) | RARBRARGRARAALDH1A1KDM4E | |
| SCHEMBL382538 | 0.97 | RARG (0.67) | RARBRARGRARAALDH1A1KDM4E | |
| SCHEMBL382049 | 0.89 | RARG (0.78) | RARBRARGRARA | |
| SCHEMBL382007 | 0.89 | RARG (0.77) | RARBRARGRARA | |
| SCHEMBL383257 | 0.88 | RARG (0.81) | RARBRARGRARAALDH1A1KDM4E | |
| SCHEMBL383570 | 0.87 | RARG (0.62) | RARBRARGRARAALDH1A1KDM4E | |
| SCHEMBL382828 | 0.87 | RARG (0.61) | RARBRARGRARAALDH1A1KMT2A | |
| SCHEMBL382166 | 0.86 | RARB (0.64) | RARBRARGRARAALDH1A1KDM4E | |
| SCHEMBL382532 | 0.86 | RARG (0.83) | RARBRARGRARA | |
| SCHEMBL382687 | 0.86 | RARB (0.63) | RARBRARGRARAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831149-B1 | NOVEL LIGANDS THAT MODULATE RAR RECEPTORS AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2012-01-25 | — | — | EP | claimed |